FDA inspection
Pegasus Laboratories, Inc.: FDA inspection ending Mar 8, 2006
FDA inspection 419254 · No Action Indicated (NAI) · Pensacola, FL
Key facts
| Inspection ID | 419254 |
|---|---|
| Firm | Pegasus Laboratories, Inc. |
| FEI number | 1038896 |
| Address | 8809 Ely St |
| City | Pensacola |
| State | FL |
| ZIP | 32514-7064 |
| Fiscal year | 2006 |
| Inspection end date | Mar 8, 2006 |
| Classification | No Action Indicated (NAI) |
| Project area | Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data